| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Styliani Vlachou, Fygaleia Stamatopoulou, George G Nomikos, George Panagi. Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the reinforcing and psychostimulant effects of cocaine. The international journal of neuropsychopharmacology. vol 11. issue 7. 2008-12-08. PMID:18377702. |
we sought to determine the effects of the endocannabinoid neurotransmission enhancer am-404 (1, 3, 10, 30 mg/kg) on the changes in icss threshold and locomotion elicited by cocaine and extend the study of the effects of win55,212-2 (0.3, 1, 3 mg/kg) on cocaine-induced hyperlocomotion. |
2008-12-08 |
2023-08-12 |
Not clear |
| Styliani Vlachou, Fygaleia Stamatopoulou, George G Nomikos, George Panagi. Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the reinforcing and psychostimulant effects of cocaine. The international journal of neuropsychopharmacology. vol 11. issue 7. 2008-12-08. PMID:18377702. |
these results indicate that cannabinoids may interfere with brain reward systems responsible for the expression of acute reinforcing/rewarding properties of cocaine, and provide further evidence that the cannabinoid system could be explored as a potential drug discovery target for the treatment of psychostimulant addiction and pathological states associated with psychomotor overexcitability. |
2008-12-08 |
2023-08-12 |
Not clear |
| Edward J Cone, Yale H Caplan, David L Black, Timothy Robert, Frank Mose. Urine drug testing of chronic pain patients: licit and illicit drug patterns. Journal of analytical toxicology. vol 32. issue 8. 2008-12-04. PMID:19007501. |
the number of drug/metabolites tested (#) and number of confirmed positive specimens were as follows: amphetamines (7), 160; barbiturates (5), 308; benzodiazepines (6), 2397; cannabinoids (1), 967; carisoprodol (2), 611; cocaine (1), 310; fentanyl (1), 458; meperidine (2), 58; methadone (2), 1209; opiates (7), 8996; and propoxyphene (2), 385. |
2008-12-04 |
2023-08-12 |
Not clear |
| Rachel J Smith, Gary Aston-Jone. Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence. Brain structure & function. vol 213. issue 1-2. 2008-12-02. PMID:18651175. |
ne and crf transmission in the extended amygdala are also implicated in the increased anxiety that occurs during prolonged abstinence from chronic opiates, cocaine, ethanol, and cannabinoids. |
2008-12-02 |
2023-08-12 |
Not clear |
| D Parolaro, T Rubin. The role of the endogenous cannabinoid system in drug addiction. Drug news & perspectives. vol 21. issue 3. 2008-11-03. PMID:18560613. |
for a long time, dopamine has been consistently associated with the reinforcing effects of most drugs of abuse but, recently, pharmacological evidence points to the possibility that pharmacological management of the endocannabinoid system might not only block the direct reinforcing effect of cannabis, opioids, nicotine and ethanol, but also prevent the relapse to various drugs of abuse including opioids, cocaine, nicotine, alcohol and amphetamine. |
2008-11-03 |
2023-08-12 |
Not clear |
| Fangqiong Li, Qin Fang, Yu Liu, Mei Zhao, Dapeng Li, Jishi Wang, Lin L. Cannabinoid CB(1) receptor antagonist rimonabant attenuates reinstatement of ketamine conditioned place preference in rats. European journal of pharmacology. vol 589. issue 1-3. 2008-10-24. PMID:18534572. |
recent evidence suggests that cannabinoid cb(1) receptors may represent effective targets for therapeutic agents used to treat cocaine and heroin relapse. |
2008-10-24 |
2023-08-12 |
rat |
| Zheng-Xiong Xi, Krista Spiller, Arlene C Pak, Jeremy Gilbert, Christopher Dillon, Xia Li, Xiao-Qing Peng, Eliot L Gardne. Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 33. issue 7. 2008-09-24. PMID:17728698. |
cannabinoid cb1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats. |
2008-09-24 |
2023-08-12 |
mouse |
| Zheng-Xiong Xi, Krista Spiller, Arlene C Pak, Jeremy Gilbert, Christopher Dillon, Xia Li, Xiao-Qing Peng, Eliot L Gardne. Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 33. issue 7. 2008-09-24. PMID:17728698. |
previous studies suggest that cannabinoid cb1 receptors do not appear to be involved in cocaine's rewarding effects, as assessed by the use of sr141716a, a prototypic cb1 receptor antagonist and cb1-knockout mice. |
2008-09-24 |
2023-08-12 |
mouse |
| Scott M Rawls, Steven Baron, Zhe Ding, Christopher Roth, Nurulain Zaveri, Robert B Raff. Nociceptin attenuates methamphetamine abstinence-induced withdrawal-like behavior in planarians. Neuropeptides. vol 42. issue 3. 2008-09-19. PMID:18479746. |
planarians display a concentration-related reduction in locomotor activity when amphetamine, cocaine, cannabinoid, or benzodiazepine exposure is abruptly discontinued. |
2008-09-19 |
2023-08-12 |
Not clear |
| J Jelsing, P J Larsen, N Vran. Identification of cannabinoid type 1 receptor expressing cocaine amphetamine-regulated transcript neurons in the rat hypothalamus and brainstem using in situ hybridization and immunohistochemistry. Neuroscience. vol 154. issue 2. 2008-08-29. PMID:18472225. |
identification of cannabinoid type 1 receptor expressing cocaine amphetamine-regulated transcript neurons in the rat hypothalamus and brainstem using in situ hybridization and immunohistochemistry. |
2008-08-29 |
2023-08-12 |
mouse |
| Dennis J Crouch, J Michael Walsh, Leo Cangianelli, Oscar Quintel. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices. Therapeutic drug monitoring. vol 30. issue 2. 2008-07-11. PMID:18367979. |
the drugwipe sensitivities were 36.4%, 35.9%, 42.9%, and 7.7%, respectively, for amphetamine(s), cocaine, opiates, and cannabinoids. |
2008-07-11 |
2023-08-12 |
human |
| Dennis J Crouch, J Michael Walsh, Leo Cangianelli, Oscar Quintel. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices. Therapeutic drug monitoring. vol 30. issue 2. 2008-07-11. PMID:18367979. |
the drugwipe specificities were 99.2%, 97.4%, 99.6%, and 99.6%, respectively, for amphetamine(s), cocaine, opiates, and cannabinoids. |
2008-07-11 |
2023-08-12 |
human |
| Alejandro Higuera-Matas, María Luisa Soto-Montenegro, Nuria del Olmo, Miguel Miguéns, Isabel Torres, Juan José Vaquero, Javier Sánchez, Carmen García-Lecumberri, Manuel Desco, Emilio Ambrosi. Augmented acquisition of cocaine self-administration and altered brain glucose metabolism in adult female but not male rats exposed to a cannabinoid agonist during adolescence. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 33. issue 4. 2008-07-03. PMID:17551541. |
augmented acquisition of cocaine self-administration and altered brain glucose metabolism in adult female but not male rats exposed to a cannabinoid agonist during adolescence. |
2008-07-03 |
2023-08-12 |
rat |
| Alejandro Higuera-Matas, María Luisa Soto-Montenegro, Nuria del Olmo, Miguel Miguéns, Isabel Torres, Juan José Vaquero, Javier Sánchez, Carmen García-Lecumberri, Manuel Desco, Emilio Ambrosi. Augmented acquisition of cocaine self-administration and altered brain glucose metabolism in adult female but not male rats exposed to a cannabinoid agonist during adolescence. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 33. issue 4. 2008-07-03. PMID:17551541. |
our results suggest that a chronic exposure to cannabinoids during adolescence alters the susceptibility to acquire cocaine self-administration, in a sex-specific fashion. |
2008-07-03 |
2023-08-12 |
rat |
| Robert B Raffa, Gregory W Stagliano, Geoffrey Ross, Jenay A Powell, Austin G Phillips, Zhe Ding, Scott M Rawl. The kappa-opioid receptor antagonist nor-BNI inhibits cocaine and amphetamine, but not cannabinoid (WIN 52212-2), abstinence-induced withdrawal in planarians: an instance of 'pharmacologic congruence'. Brain research. vol 1193. 2008-06-03. PMID:18178175. |
the kappa-opioid receptor antagonist nor-bni inhibits cocaine and amphetamine, but not cannabinoid (win 52212-2), abstinence-induced withdrawal in planarians: an instance of 'pharmacologic congruence'. |
2008-06-03 |
2023-08-12 |
Not clear |
| Robert B Raffa, Gregory W Stagliano, Geoffrey Ross, Jenay A Powell, Austin G Phillips, Zhe Ding, Scott M Rawl. The kappa-opioid receptor antagonist nor-BNI inhibits cocaine and amphetamine, but not cannabinoid (WIN 52212-2), abstinence-induced withdrawal in planarians: an instance of 'pharmacologic congruence'. Brain research. vol 1193. 2008-06-03. PMID:18178175. |
we report here: (1) amphetamine abstinence-induced withdrawal, and (2) the attenuation of cocaine and amphetamine, but not cannabinoid agonist (win 52212-2), abstinence-induced withdrawal by the opioid receptor antagonist naloxone and by the selective kappa-opioid receptor subtype antagonist nor-bni (nor-binaltorphimine), but not by the selective mu-opioid or the delta-opioid receptor subtype antagonists ctap (d-phe-cys-tyr-d-trp-arg-thr-pen-thr-nh(2)) and naltrindole. |
2008-06-03 |
2023-08-12 |
Not clear |
| Robert B Raffa, Gregory W Stagliano, Geoffrey Ross, Jenay A Powell, Austin G Phillips, Zhe Ding, Scott M Rawl. The kappa-opioid receptor antagonist nor-BNI inhibits cocaine and amphetamine, but not cannabinoid (WIN 52212-2), abstinence-induced withdrawal in planarians: an instance of 'pharmacologic congruence'. Brain research. vol 1193. 2008-06-03. PMID:18178175. |
these results provide evidence that the withdrawal from cocaine and amphetamine, but not cannabinoids, in planarians is mediated through a common nor-bni-sensitive (kappa-opioid receptor-like) pathway. |
2008-06-03 |
2023-08-12 |
Not clear |
| Bente Glintborg, Lenette Olsen, Henrik Poulsen, Kristian Linnet, Kim Dalhof. Reliability of self-reported use of amphetamine, barbiturates, benzodiazepines, cannabinoids, cocaine, methadone, and opiates among acutely hospitalized elderly medical patients. Clinical toxicology (Philadelphia, Pa.). vol 46. issue 3. 2008-05-06. PMID:18344106. |
reliability of self-reported use of amphetamine, barbiturates, benzodiazepines, cannabinoids, cocaine, methadone, and opiates among acutely hospitalized elderly medical patients. |
2008-05-06 |
2023-08-12 |
Not clear |
| Bente Glintborg, Lenette Olsen, Henrik Poulsen, Kristian Linnet, Kim Dalhof. Reliability of self-reported use of amphetamine, barbiturates, benzodiazepines, cannabinoids, cocaine, methadone, and opiates among acutely hospitalized elderly medical patients. Clinical toxicology (Philadelphia, Pa.). vol 46. issue 3. 2008-05-06. PMID:18344106. |
the aim of the present study was to estimate the reliability of self-reported use of amphetamine, barbiturates, benzodiazepines, cannabinoids, cocaine, methadone, and opiates among acutely hospitalized medical patients. |
2008-05-06 |
2023-08-12 |
Not clear |
| C Stramesi, M Polla, C Vignali, A Zucchella, A Gropp. Segmental hair analysis in order to evaluate driving performance. Forensic science international. vol 176. issue 1. 2008-04-10. PMID:17996414. |
about hair samples, this memorandum advises that the proximal lock of 6 cm-length would be analysed for opiates, cocaine, cannabinoids, amphetamine and derivatives, divided into two segments of 3 cm each. |
2008-04-10 |
2023-08-12 |
human |